Pediatrix Medical Group, Inc. 8-K

What Happened

• On May 5, 2026, Pediatrix Medical Group, Inc. announced its results of operations for the three months ended March 31, 2026 via a press release (the "First Quarter Release"). The press release is attached to the Form 8‑K as Exhibit 99.1 and is incorporated by reference into the filing. The report was signed by Kasandra H. Rossi, Chief Financial Officer.

Key Details

• Filing date: May 5, 2026 (Form 8‑K).
• Reporting period: three months ended March 31, 2026 (Q1 2026).
• Exhibit attached: Exhibit 99.1 — First Quarter press release (also referenced in the filing).
• Report signed by: Kasandra H. Rossi, Chief Financial Officer.

Why It Matters

• This 8‑K notifies investors that Pediatrix has released its quarterly earnings information; those results (revenue, earnings, margins or guidance if provided in the release) can affect the company’s stock and investor decisions. Retail investors should read the attached press release (Exhibit 99.1) for the detailed financial figures and management commentary.